Established as part of the Brain and Mind Centre, the Lambert Initiative conducts high quality research to discover, develop and optimise safe and effective cannabinoid therapeutics in medicine.
The Lambert Initiative provides national and international leadership both in the science of medicinal cannabis and in the discovery and development of cannabis-based medicines.
Our activities extend from plant science and cannabinoid production, through cellular and preclinical pharmacology, to medicinal chemistry and drug discovery, including human laboratory studies and clinical trials.
We also act in an advocacy and educational capacity. We provide evidence and guidance for clinicians, consumers, health professionals and politicians about the potential of cannabinoid therapeutics. We also seek to influence regulatory approaches and public health policy.
We develop knowledge aimed at maximising the potential of cannabinoid medicines to treat a range of human diseases, particularly where there is currently an unmet need for novel treatments.
These conditions include, but are not limited to:
Our vision is to conduct the high quality research required to discover, develop and optimise safe and effective cannabinoid therapeutics in Australia and beyond.
Over the next three years, we aim to:
In our first year of operation, we have:
From the age of six months, the Lamberts’ young granddaughter Caitlyn suffered with Dravet Syndrome seizures. Here they explain how illegal cannabis paste stopped her seizures, and how the incredible transformation led the couple to donate $33.7M to the University of Sydney for medicinal cannabis research. Professor Iain McGregor shows us inside the Lambert Initiative lab making headway in cannabinoid therapeutics. (Footage courtesy of Channel 9).